Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. (Q51680964)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2010

Language	Label	Description	Also known as
English	Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.	scientific article published in July 2010

Statements

scholarly article

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. (English)

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

object named as

Hong Ding

2

0 references

author name string

Na Li

1

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Peili Fan

3

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Xiyuan Lin

4

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Chen Xu

5

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Wenping Wang

6

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Zhizhang Xu

7

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Jiyao Wang

8

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

publication date

1 July 2010

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Ultrasound in Medicine and Biology

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

36

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

7

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

1066-1075

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Parameters of cerebral perfusion in phase-inversion harmonic imaging (PIHI) ultrasound examinations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Non-invasive evaluation of liver cirrhosis using ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Semiquantitative analysis of ultrasonic cerebral perfusion imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic vein transit time of SonoVue: a comparative study with Levovist.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Chronic hepatitis B: update of recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Validation of ultrasound contrast destruction imaging for flow quantification

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Quantification of hepatic parenchymal blood flow by contrast ultrasonography with flash-replenishment imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic transit time of ultrasound contrast in biopsy characterized liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Fibrosis and cirrhosis reversibility: clinical features and implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Contrast agent specific imaging modes for the ultrasonic assessment of parenchymal cerebral echo contrast enhancement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

The role of liver biopsy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

The nomenclature of chronic hepatitis: time for a change.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Direct and indirect evidence for the reversibility of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.ULTRASMEDBIO.2010.04.012

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51680964&oldid=2152073590"